Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Wellmarker Bio
Celon Pharma SA
Zhejiang University
Wellmarker Bio
Peking University Cancer Hospital & Institute
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Taizhou EOC Pharma Co., Ltd.
University Hospital, Geneva